IL110413A0 - Agonists and antagonists of human interleukin-10 - Google Patents
Agonists and antagonists of human interleukin-10Info
- Publication number
- IL110413A0 IL110413A0 IL11041394A IL11041394A IL110413A0 IL 110413 A0 IL110413 A0 IL 110413A0 IL 11041394 A IL11041394 A IL 11041394A IL 11041394 A IL11041394 A IL 11041394A IL 110413 A0 IL110413 A0 IL 110413A0
- Authority
- IL
- Israel
- Prior art keywords
- agonists
- antagonists
- human interleukin
- interleukin
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9894393A | 1993-07-26 | 1993-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL110413A0 true IL110413A0 (en) | 1994-10-21 |
Family
ID=22271670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11041394A IL110413A0 (en) | 1993-07-26 | 1994-07-22 | Agonists and antagonists of human interleukin-10 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0711346A1 (xx) |
JP (1) | JPH08507930A (xx) |
KR (1) | KR960704041A (xx) |
CN (1) | CN1127529A (xx) |
AU (1) | AU681178B2 (xx) |
CA (1) | CA2168110A1 (xx) |
CZ (1) | CZ23396A3 (xx) |
FI (1) | FI960353A (xx) |
HU (1) | HUT73463A (xx) |
IL (1) | IL110413A0 (xx) |
NO (1) | NO960309D0 (xx) |
NZ (1) | NZ269663A (xx) |
PL (1) | PL312718A1 (xx) |
SG (1) | SG43798A1 (xx) |
SK (2) | SK150596A3 (xx) |
WO (1) | WO1995003411A1 (xx) |
ZA (1) | ZA945434B (xx) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK283096B6 (sk) | 1994-07-05 | 2003-02-04 | Steeno Research Group A/S | Imunomodulátory |
GB2304047A (en) | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
AUPN481295A0 (en) * | 1995-08-16 | 1995-09-07 | Medvet Science Pty. Ltd. | Agonists of haemopoietic growth factors |
WO1997026278A1 (en) | 1996-01-18 | 1997-07-24 | Steeno Research Group A/S | Synthetic il-10 analogues |
DE19851675A1 (de) * | 1998-11-10 | 2000-05-11 | Bayer Ag | Menschliche Interleukin-10 Mutantenproteine |
EP1283722A1 (en) | 2000-03-31 | 2003-02-19 | Idec Pharmaceuticals Corporation | Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma |
ES2367891T3 (es) | 2000-09-29 | 2011-11-10 | Schering Corporation | Interleucina-10 pegilada. |
US7261882B2 (en) | 2003-06-23 | 2007-08-28 | Reagents Of The University Of Colorado | Methods for treating neuropathic pain by administering IL-10 polypeptides |
EP1712241A1 (en) | 2005-04-15 | 2006-10-18 | Centre National De La Recherche Scientifique (Cnrs) | Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
EP1885863B1 (en) | 2005-05-31 | 2014-11-19 | The Regents of the University of Colorado, a body corporate | Methods for delivering genes |
NZ597098A (en) | 2006-09-28 | 2013-05-31 | Merck Sharp & Dohme | Use of pegylated il-10 to treat cancer |
WO2010040105A2 (en) | 2008-10-02 | 2010-04-08 | Trubion Pharmaceuticals, Inc. | Cd86 antagonist multi-target binding proteins |
AU2009333325B2 (en) | 2008-12-17 | 2014-07-10 | Merck Sharp & Dohme Corp. | Mono- and di-peg IL-10 production; and uses |
CN108129574A (zh) | 2011-11-08 | 2018-06-08 | Umc乌德勒支控股有限公司 | 包括白细胞介素10和白细胞介素4的融合蛋白 |
JP2016519108A (ja) | 2013-04-18 | 2016-06-30 | アルモ・バイオサイエンシーズ・インコーポレイテッド | インターロイキン−10を疾病及び疾患の治療に用いる方法 |
WO2014176373A2 (en) * | 2013-04-24 | 2014-10-30 | Armo Biosciences, Inc. | Interleukin-10 compositions and uses thereof |
US9823255B2 (en) | 2013-06-17 | 2017-11-21 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
CN105658232A (zh) | 2013-08-30 | 2016-06-08 | 阿尔莫生物科技股份有限公司 | 使用白细胞介素-10治疗疾病和病症的方法 |
ES2862139T3 (es) | 2013-11-11 | 2021-10-07 | Armo Biosciences Inc | Procedimientos de uso de Interleucina 10 para el tratamiento de enfermedades y trastornos |
WO2015187295A2 (en) | 2014-06-02 | 2015-12-10 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
EP3206713A4 (en) | 2014-10-14 | 2018-06-27 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
US10143726B2 (en) | 2014-10-22 | 2018-12-04 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
WO2016126615A1 (en) | 2015-02-03 | 2016-08-11 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
KR20180020141A (ko) | 2015-05-28 | 2018-02-27 | 아르모 바이오사이언시스 인코포레이티드 | 암 치료에 사용되는 peg화된 인터류킨-10 |
MX2018002298A (es) | 2015-08-25 | 2018-07-06 | Armo Biosciences Inc | Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos. |
GB2600564B (en) | 2019-04-19 | 2024-02-28 | Synerkine Pharma B V | A fusion protein comprising IL13 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01113229A (ja) * | 1987-10-27 | 1989-05-01 | Inahata Kenkyusho:Kk | 多孔質ハニカム構成材 |
IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
CA2115060C (en) * | 1991-08-06 | 2003-05-06 | Rene De Waal Malefyt | Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
-
1994
- 1994-07-22 WO PCT/US1994/008052 patent/WO1995003411A1/en not_active Application Discontinuation
- 1994-07-22 SK SK1505-96A patent/SK150596A3/sk unknown
- 1994-07-22 NZ NZ269663A patent/NZ269663A/en unknown
- 1994-07-22 CA CA002168110A patent/CA2168110A1/en not_active Abandoned
- 1994-07-22 EP EP94923956A patent/EP0711346A1/en not_active Withdrawn
- 1994-07-22 SK SK83-96A patent/SK8396A3/sk unknown
- 1994-07-22 KR KR1019960700358A patent/KR960704041A/ko not_active Application Discontinuation
- 1994-07-22 CZ CZ96233A patent/CZ23396A3/cs unknown
- 1994-07-22 PL PL94312718A patent/PL312718A1/xx unknown
- 1994-07-22 HU HU9503983A patent/HUT73463A/hu unknown
- 1994-07-22 CN CN94192880A patent/CN1127529A/zh active Pending
- 1994-07-22 IL IL11041394A patent/IL110413A0/xx unknown
- 1994-07-22 AU AU73996/94A patent/AU681178B2/en not_active Ceased
- 1994-07-22 ZA ZA945434A patent/ZA945434B/xx unknown
- 1994-07-22 JP JP7505238A patent/JPH08507930A/ja active Pending
- 1994-07-22 SG SG1996000969A patent/SG43798A1/en unknown
-
1996
- 1996-01-25 NO NO960309A patent/NO960309D0/no unknown
- 1996-01-26 FI FI960353A patent/FI960353A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
AU681178B2 (en) | 1997-08-21 |
SG43798A1 (en) | 1997-11-14 |
HUT73463A (en) | 1996-08-28 |
WO1995003411A1 (en) | 1995-02-02 |
ZA945434B (en) | 1995-01-23 |
CZ23396A3 (en) | 1996-05-15 |
CA2168110A1 (en) | 1995-02-02 |
CN1127529A (zh) | 1996-07-24 |
NO960309L (no) | 1996-01-25 |
FI960353A0 (fi) | 1996-01-26 |
NO960309D0 (no) | 1996-01-25 |
SK8396A3 (en) | 1997-03-05 |
PL312718A1 (en) | 1996-05-13 |
AU7399694A (en) | 1995-02-20 |
FI960353A (fi) | 1996-01-26 |
JPH08507930A (ja) | 1996-08-27 |
NZ269663A (en) | 1997-09-22 |
EP0711346A1 (en) | 1996-05-15 |
HU9503983D0 (en) | 1996-03-28 |
SK150596A3 (en) | 1997-04-09 |
KR960704041A (ko) | 1996-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA945434B (en) | Agonists and antagonists of human interleukin-10 | |
EP0880356A4 (en) | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | |
GB9300213D0 (en) | Wrist and hand support | |
IL106732A0 (en) | Human interleukin-13 | |
ZA936097B (en) | Human interleukin-13 | |
AR243240A1 (es) | Procedimiento para preparar una proteina con actividad de factor estimulador de colonia y acido nucleico que comprende una secuencia nucleotidica capaz de modificarla. | |
ZA9710979B (en) | Novel heterocyclically substituted benzamides and their use | |
EP0586687A4 (en) | Trans-sialidase and methods of use and making thereof | |
EP0729300A4 (en) | FAS PROTEIN AND METHOD FOR ITS USE | |
HU9600241D0 (en) | Mutable composition and methods of use thereof | |
EP0445801A3 (en) | Peptide and its use | |
HU9402361D0 (en) | New makrolides and use of them | |
AP9300555A0 (en) | Therapeutic agent and its use | |
AU4596896A (en) | Substituted benzamides and radioligand analogs and methods of use | |
ZA899778B (en) | Reduction of piperidine-dion-derivatives and intermediates | |
AU3681795A (en) | Polypeptide agonists and antagonists of human interleukin-8 | |
GB2294637B (en) | Therapeutic compositions and methods of use | |
HUP9800146A3 (en) | Thalidomide-derivatives and use of them | |
GB8923571D0 (en) | Connecting means and method of use thereof | |
PL307138A1 (en) | Amyline antagonists and agonists | |
EP0540575A4 (en) | Human meg-csf protein and methods | |
KR910007551B1 (en) | Polyethylene terephchalate and its use | |
GB9501907D0 (en) | Allatostatins and their use | |
GB9314512D0 (en) | Composition and use | |
ZA942246B (en) | Novel imidazolo-quinoxalinones their preparation and use |